THE Board of Investments (BOI) on Monday said it has cleared the application of Lloyd Laboratories Inc. to be the domestic producer of Molnupiravir, an oral therapy for Covid-19 patients.

In a statement, BOI said the P24-million project was approved for complying with the qualification requirements for 'All Qualified Activities Relating to the Fight against the Covid-19 Pandemic — Essential Goods' Listing of the 2020 IPP as the transitional Strategic Investment Priorities Plan (SIPP) under the Corporate Recovery and Tax Incentives for Enterprises Act (Create) Law.